CA1305142C - Agent therapeutique pour les maladies neurologiques - Google Patents

Agent therapeutique pour les maladies neurologiques

Info

Publication number
CA1305142C
CA1305142C CA 552445 CA552445A CA1305142C CA 1305142 C CA1305142 C CA 1305142C CA 552445 CA552445 CA 552445 CA 552445 A CA552445 A CA 552445A CA 1305142 C CA1305142 C CA 1305142C
Authority
CA
Canada
Prior art keywords
carbon atoms
group
compound
formula
agent according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 552445
Other languages
English (en)
Inventor
Ikuo Tomino
Akira Awaya
Takuo Nakano
Takumi Kitahara
Ken-Ei Tan
Tadayuki Sasaki
Kozi Kato
Kazutoshi Horikomi
Hisashi Kobayashi
Keiichi Yokoyama
Hiroyasu Ohno
Shigeru Isayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Pharmaceuticals Inc
Original Assignee
Mitsui Pharmaceuticals Inc
Mitsui Petrochemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Pharmaceuticals Inc, Mitsui Petrochemical Industries Ltd filed Critical Mitsui Pharmaceuticals Inc
Priority to CA 552445 priority Critical patent/CA1305142C/fr
Application granted granted Critical
Publication of CA1305142C publication Critical patent/CA1305142C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 552445 1987-11-23 1987-11-23 Agent therapeutique pour les maladies neurologiques Expired - Fee Related CA1305142C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 552445 CA1305142C (fr) 1987-11-23 1987-11-23 Agent therapeutique pour les maladies neurologiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 552445 CA1305142C (fr) 1987-11-23 1987-11-23 Agent therapeutique pour les maladies neurologiques

Publications (1)

Publication Number Publication Date
CA1305142C true CA1305142C (fr) 1992-07-14

Family

ID=4136895

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 552445 Expired - Fee Related CA1305142C (fr) 1987-11-23 1987-11-23 Agent therapeutique pour les maladies neurologiques

Country Status (1)

Country Link
CA (1) CA1305142C (fr)

Similar Documents

Publication Publication Date Title
EP0257102B1 (fr) Agents therapeutiques de la neuropathie
EP0379806B1 (fr) Pyrimidines et leurs sels acceptables en pharmacie, et leur utilisation comme médicaments
US6251900B1 (en) Heterocyclic compounds and antitumor agent containing the same as active ingredient
EP0633886B1 (fr) Amines bicycliques-heterocycliques efficaces pharmaceutiquement
DK172884B1 (da) Analogifremgangsmåde til fremstilling af i 5-stilling substituerede 2,4-diaminopyrimidiner og mellemprodukter til anvendels
DE68929049T2 (de) 1,4-Diazepin-Derivate und deren pharmazeutische Verwendung
AU2012327780B2 (en) Kinase inhibitor and method for treatment of related diseases
PT93823B (pt) Processo para a preparacao de derivados de pirimidina e de composicoes farmaceuticas que os contem
US5304555A (en) Pyrimidines and pharmaceutically acceptable salts thereof useful in treatment of neurological disorders
PT1603915E (pt) Derivados de 8„-piridinil-di-hidrospiro-cicloalquilpirimido( 1,2-a)pirimidin-6-ona e de 8„-pirimidinil-dihidrospiro- cicloalquil-pirimido(1,2-a)pirimidin-6-ona substitudos e sua utilizaã†o contra doenãas neurodegenerativas
EP0150469B1 (fr) Dérivés de thiéno (2,3-d)pyrimidine et leurs sels
US5852019A (en) Pyrimidinylpyrazole derivatives
DE3650384T2 (de) Antivirale Purin-Derivate und Verfahren zu ihrer Herstellung.
EP0177287B1 (fr) Dérivés pyrimidiniques, procédé pour leur préparation et compositions les contenant
DK156722B (da) Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater
EP0305184B1 (fr) Pyrimidines et leurs sels pharmaceutiquement acceptables
CA1305142C (fr) Agent therapeutique pour les maladies neurologiques
AU694853B2 (en) Pyrimido{4,5-b}indoles
EP0489925B1 (fr) Compose de pyrimidine et sel pharmaceutiquement acceptable de ce compose
JPH08325268A (ja) ピロロ〔３，４−ｄ〕ピリミジン誘導体
JP2628707B2 (ja) ピリミジン類及びその薬学的に許容される塩類
US3320256A (en) Fluorinated imidazoo[1, 2-c]pyrimidines and pyrimido[1, 2-c]pyrimidines
JP2744663B2 (ja) ピリミジン類及びその薬学的に許容される塩類
JP2561689B2 (ja) 神経疾患用治療薬
KR20050113218A (ko) 치환된 2-(디아자-비시클로-알킬)-피리미돈 유도체

Legal Events

Date Code Title Description
MKLA Lapsed